LIC Share Price In Focus: LIC OFS Expansion, Paytm Block Deals, And New Listings On August 5

Nidhi Thakur

August 5, 2026

Key Takeaways

LIC OFS Expanded To 6.5% Stake With An Oversubscription Option Adding 50.59 Crore Equity Shares
Paytm Block Deals Total ₹2,038.02 Crore Across Elevation Capital V, SAIF III Mauritius, And SAIF Partners India IV
Meesho And Poonawalla Fincorp Block Deals Signal Strong Institutional Interest And Price Discovery
Manipal Health Enterprises Listing And Ex-Dividend Actions Create Near-Term Catalysts

As August 5 dawns, retail investors face a crucial question: Will the LIC Share Price respond to the expanded OFS and the flood of block deals across Paytm, Meesho, and Poonawalla Fincorp? The government has exercised the oversubscription option in the ongoing LIC OFS, expanding the stake to 6.5% and adding 50.59 crore equity shares to the base issue of 31.62 crore shares. The additional shares, representing 4% of equity, sit on top of a base 2.5% equity. In practice, near-term moves will depend on how market participants price the incremental government stake while catching the broader market mood on August 5.

LIC Share Price In Focus As LIC OFS Expansion Unfolds

The OFS expansion to 6.5% is anchored by an oversubscription option that adds 50.59 crore equity shares, equaling 4% of total equity, above the base issue of 31.62 crore shares (2.5%). The resulting trajectory for the LIC Share Price will hinge on the bid-book formation, demand from retail investors, and the appetite of institutional buyers participating in the OFS. The stock’s price movement will also reflect liquidity conditions as the government stake increases. Since LIC remains a key pillar of India’s financial system, price responses can ripple into sentiment across related financials and insurance stocks. Traders should monitor exchange disclosures on OFS allotment and any commentary from market participants about the bid-book fill rate.

Download App Now

Paytm Stock: Large Block Deals And The Implications For Paytm Stock Price

Paytm witnessed three major block deals totaling 1.49 crore shares worth ₹2,038.02 crore. Elevation Capital V sold 10.20 lakh shares worth ₹139.55 crore; SAIF III Mauritius Company divested 97.43 lakh shares worth ₹1,332.7 crore; and SAIF Partners India IV offloaded 41.36 lakh shares worth ₹565.77 crore. Buyers included National Pension System Trust, Axis Mutual Fund, Morgan Stanley, Goldman Sachs, BNP Paribas Financial Markets, Societe Generale, Franklin Templeton Mutual Fund, Tata Mutual Fund, and several other institutional investors. This pattern of demand can influence Paytm stock price in the near term as supply tightens on the back of heavy selling pressure. The price action will likely be shaped by how the trades settle and the liquidity dynamics in the Paytm market.

The block deals highlight a broader pattern where institutional interest can drive near-term volatility, even as the longer-term trajectory depends on Paytm’s fundamental growth and user metrics. Traders should observe how the stock behaves in the coming sessions and whether price consolidation emerges around key psychological levels. For deeper, data-driven insights into how such deals translate into price movement, investors can explore research tools that aggregate trade details and quantify potential outcomes for different price paths.

To help readers visualize these block-deal numbers, here is a compact table summarizing the Paytm transactions and related movements in Meesho’s ecosystem.

Deal / Company	Shares or Stake	Value (₹ crore)	Price (₹)
Paytm – Elevation Capital V	10.20 Lakh	139.55	To be announced
Paytm – SAIF III Mauritius	97.43 Lakh	1,332.70	To be announced
Paytm – SAIF Partners India IV	41.36 Lakh	565.77	To be announced
Meesho – Elevation Capital & Peak XV	2.27% stake	1,949.00	186

In parallel, Goldman Sachs India Equity Portfolio reportedly acquired a 1.04% stake in Sudeep Pharma for nearly ₹100 crore, underscoring cross-border investor interest in Indian pharma plays. Block-deal activity was also reported in Zota Health Care, Rajgor Castor Derivatives, Aimtron Electronics, and Apollo Pipes, signaling broad appetite for selective mid- and small-cap opportunities amid improving risk sentiment. For investors who want to translate these signals into a structured approach, Swastika's Sarthi AI stock assistant can provide institutional-grade insights tailored to your portfolios. Swastika's Sarthi AI stock assistant can help you dissect block-deal flows and their potential implications for price action.

Download App Now

Meesho And Poonawalla Fincorp Block Deals: What Investors Should Know

In a separate wave of deal activity, Elevation Capital and Peak XV Partners Investments sold a 2.27% stake in Meesho to 27 investors for ₹1,949 crore at ₹186 per share. Buyers included Fidelity, Goldman Sachs, Morgan Stanley, Axis Mutual Fund, UTI Mutual Fund, HSBC, and the Abu Dhabi Investment Authority, among others. The Meesho block deals signal sustained institutional interest and the potential for price discovery as liquidity returns to the micro-cap consumer internet space. Investors should monitor how Meesho’s business fundamentals, growth trajectory, and execution metrics interact with the new ownership structure to influence the stock’s path in the coming weeks.

Separately, the PFL Employee Welfare Trust sold a 0.53% stake in Poonawalla Fincorp through block deals worth ₹222.96 crore at ₹473.5 per share. Purchasers included Sundaram Mutual Fund, HDFC Life Insurance Company, Helios Mutual Fund, and Morgan Stanley Asia Singapore, illustrating broad-based demand across mutual funds and financial institutions. The combination of these transactions indicates a robust market for mid-cap financials with liquidity support from diverse buyers and potential valuation readjustments as the deals settle. In addition, the Goldman Sachs India Equity Portfolio acquired a 1.04% stake in Sudeep Pharma for nearly ₹100 crore, highlighting global appetite for Indian pharma names amid a constructive risk environment. Block-deal activity was also reported in Zota Health Care, Rajgor Castor Derivatives, Aimtron Electronics, and Apollo Pipes, underscoring a broader pattern of liquidity flowing into selective segments.

To help readers visualize these block-deal numbers, here is a compact table summarizing the major Paytm and Meesho transactions and the new stake movements in related firms.

Deal / Company	Shares or Stake	Value (₹ crore)	Price (₹)
Paytm – Elevation Capital V	10.20 Lakh	139.55	139.55
Paytm – SAIF III Mauritius	97.43 Lakh	1,332.70	To be announced
Paytm – SAIF Partners India IV	41.36 Lakh	565.77	473.5
Meesho – Elevation Capital & Peak XV	2.27% stake	1,949.00	186

Manipal Health Enterprises Listing And Ex-Dividend Watch On August 5

Manipal Health Enterprises is slated for its mainboard listing, signaling a milestone for a leading healthcare provider with a diversified service mix and growth prospects. Separately, H R Hygiene Products will debut on the SME platform, offering a different risk-reward profile for investors seeking exposure to niche consumer-healthcare products. August 5 also features an ex-dividend calendar that includes Hyundai Motor India, Ajanta Pharma, Berger Paints India, Brigade Enterprises, Bayer CropScience, IRB Infrastructure Developers, Somany Ceramics, and Updater Services, with SAB Events & Governance Now Media trading ex-date under its resolution plan with suspension. These actions collectively contribute to a day with heightened trading activity and selective opportunities for capturing value from corporate actions.

Frequently Asked Questions

What is LIC OFS and how does it affect the LIC share price?

LIC OFS refers to the government's offer-for-sale of Life Insurance Corporation of India. In this instance, the offer expanded to 6.5% stake with an oversubscription option, adding 50.59 crore equity shares on top of a base issue of 31.62 crore shares, representing 4% above the base and 2.5% for the base equity. Price formation will depend on bid-book strength and market demand during the OFS, influencing the LIC share price through new supply and investor sentiment.

What were the major Paytm block deals and who were the buyers?

Three Paytm block deals totaled 1.49 crore shares worth ₹2,038.02 crore. Elevation Capital V sold 10.20 lakh shares for ₹139.55 crore; SAIF III Mauritius Company sold 97.43 lakh shares for ₹1,332.7 crore; SAIF Partners India IV offloaded 41.36 lakh shares for ₹565.77 crore. Buyers included National Pension System Trust, Axis Mutual Fund, Morgan Stanley, Goldman Sachs, BNP Paribas Financial Markets, Societe Generale, Franklin Templeton Mutual Fund, Tata Mutual Fund and others.

Which companies are listing on August 5 and what do these listings mean for investors?

Manipal Health Enterprises is scheduled for a mainboard listing, signaling growth and diversification in healthcare services. H R Hygiene Products will debut on the SME platform, which typically offers higher risk-reward and niche exposure. Listings often bring new liquidity and price discovery opportunities, but also require careful assessment of the company’s fundamentals and market demand.

Which stocks are in the ex-dividend calendar for August 5 and how should investors react?

Ex-dividend stocks on August 5 include Hyundai Motor India, Ajanta Pharma, Berger Paints India, Brigade Enterprises, Bayer CropScience, IRB Infrastructure Developers, Somany Ceramics, and Updater Services, with SAB Events & Governance Now Media trading ex-date under a resolution plan with suspension. Investors should adjust their positions accordingly, as ex-dividend dates typically cause price adjustments to reflect the new dividend entitlement. Always verify the exact ex-date with your broker or exchange filings.

What should I watch for LIC share price in the near term given the F&O ban?

LIC share price remains on the F&O ban list, which can influence intraday volatility and price discovery dynamics. Traders should monitor liquidity, bid-book strength for the LIC OFS, and market-wide cues along with movements in other watchlist stocks like Bharti Airtel, ONGC, Nykaa, Marico, MCX, Sheela Foam, Metropolis Healthcare, Deepak Nitrite, and Kalyan Jewellers. The overall takeaway is to focus on price discovery signals and risk management rather than chasing immediate swings.

Conclusion

Retail investors should treat August 5 as a day of price discovery across LIC, Paytm, Meesho, and Poonawalla Fincorp: the LIC Share Price could respond to the expanded OFS and large block deals while ex-dividend actions add volatility. The near-term signal is to watch how the bid-book fills and how prices settle as new liquidity enters the market.

Open your trading and demat account here

DISCLAIMER:

^{The information contained herein are strictly confidential and are meant solely for the information of the recipient and shall not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written permission of Swastika Investmart Ltd. (“SIL”). The contents of this document are for information purpose only. This document is not an investment advice and must not alone be taken as the basis for an investment decision. Before taking any decision to invest, the recipient of this document must read carefully the Red Herring Prospectus (“RHP”) issued to know the details of IPO and various risks and uncertainties associated with the investment in the IPO of the Company. All recipients of this document must before acting on the given information/details, make their own investigation and apply independent judgment based on their specific investment objectives and financial position. They can also seek appropriate professional advice from their own legal and tax consultants, advisors, etc. to understand the risks and investment considerations arising from such investment. The investor should possess appropriate resources to analyze such investment and the suitability of such investment to such investor’s particular circumstances before making any decisions on the investment. The Investor shall be solely responsible for any action taken based on this document. SIL shall not be liable for any direct or indirect losses arising from the use of the information contained in this document and accept no responsibility for statements made otherwise issued or any other source of information received by the investor and the investor would be doing so at his/her/its own risk. The information contained in this document should not be construed as forecast or promise or guarantee or assurance of any kind. The investors are not being offered any assurance or guaranteed or fixed returns on their investments. The users of this document must bear in mind that past performances if any, are not indicative of future results. The actual returns on investment may be materially different than the past. Investments in Securities market products and instruments including in the IPO of the Company are highly risky and they are generally not an appropriate avenue for someone with limited resources/ limited investment and low risk tolerance. Such Investments are subject to market risks including, without limitation, price, volatility and liquidity and capital risks. Therefore, the users of this document must carefully consider all the information given in the RHP including the risks factors before making any investment in the Equity Shares of the Company.Swastika Investmart Ltd or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither Swastika Investmart Ltd nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Swastika Investment Ltd may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the Subject Company or third party in connection with the Research Report.CORPORATE & ADMINISTRATIVE OFFICE - 48, Jaora Compound, M.Y.H. Road, Indore - 452 001 | Phone 0731 - 6644000 Compliance Officer: Dimple Soni. Email: compliance@swastika.co.in Phone: (0731) 6644 241 Swastika Investmart Limited, SEBI Reg. No. : NSE/BSE/MSEI: INZ000192732 Merchant Banking: INM000012102 Investment Adviser: INA000009843 MCX/NCDEX: INZ000072532 CDSL/NSDL: IN-DP-115-2015 RBI Reg. No.: B-03-00174 IRDA Reg. No.: 713. Research Analyst Registration Number: INH000024073}